Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × exemestane × Clear all

Sponsor

Conditions

Breast Neoplasms 67 Neoplasm Metastasis 6 Breast Neoplasms, Male 3 Neoplasms 2 Arthralgia 2 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1 Skin Diseases 1 Post Menopausal Women With Early Breast Cancer 1 Pain 1 Obesity 1 Metastatic Beast Cancer 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Invasive Early Breast Cancer 1 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1 Fatigue 1 Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Advanced Breast Carcinoma 1 Advanced Breast Cancer 1

Interventions

Sorafenib 49 pembrolizumab 20 Nivolumab 18 Bevacizumab 16 Radiosurgery 15 Doxorubicin 12 lenvatinib 8 Erlotinib Hydrochloride 7 atezolizumab 6 Ramucirumab 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 cabozantinib 5 Radiofrequency Ablation 5 tislelizumab 4 Sunitinib 4 Ipilimumab 4 regorafenib 3 nintedanib 3 carotuximab 3 bavituximab 3 Ribavirin 3 Radiotherapy 3 Oxaliplatin 3 Mitomycin 3 Leucovorin 3 Fluorouracil 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡